Maxcyte (MXCT) EBIT Margin (2020 - 2026)

Maxcyte (MXCT) reported EBIT Margin of 64.09% for Q1 2026, up 15000.0% year-over-year from N/an in Q1 2025, and up 90.24% on a QoQ basis from 656.3% in Q4 2025.

Maxcyte (MXCT) has 7 years of EBIT Margin data on file, last reported at 64.09% in Q1 2026.

  • Quarterly EBIT Margin rose 15000.0% year-over-year to 64.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.6% (up 1261.0% YoY) and the FY2025 annual result came in at 44.72%, down 2250.0% from the prior year.
  • EBIT Margin grew to 64.09% in Q1 2026 per MXCT's latest filing, from 656.3% in the prior quarter.
  • Across five years, EBIT Margin topped out at 341.8% in Q4 2024 and bottomed at 656.3% in Q4 2025.
  • The 5-year median for EBIT Margin is 172.13% (2024), against an average of 153.49%.
  • The widest annual swing landed in 2024, when EBIT Margin soared 51203 bps; it then plunged 99810 bps in 2025.
  • Tracing MXCT's EBIT Margin over 5 years: stood at 218.48% in 2022, then slumped by 178 bps to 170.23% in 2023, then soared by 301 bps to 341.8% in 2024, then tumbled by 292 bps to 656.3% in 2025, then jumped by 90 bps to 64.09% in 2026.
  • Per Business Quant, the three latest MXCT EBIT Margin figures stand at 64.09% (Q1 2026), 656.3% (Q4 2025), and 207.19% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn -64.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -64.09%
Dec 31, 2025 -656.30%
Sep 30, 2025 -207.19%
Jun 30, 2025 -244.28%
Mar 31, 2025 -214.09%
Dec 31, 2024 341.80%
Sep 30, 2024 -172.13%
Jun 30, 2024 -241.10%
Mar 31, 2024 -219.82%
Dec 31, 2023 -170.23%
Sep 30, 2023 -335.71%
Jun 30, 2023 -144.56%
Mar 31, 2023 -265.47%
Dec 31, 2022 218.48%
Sep 30, 2022 -107.83%
Jun 30, 2022 -90.96%
Mar 31, 2022 -35.89%
Dec 31, 2021 228.28%
Sep 30, 2021 -43.56%
Jun 30, 2021 -62.14%
Mar 31, 2021 -150.34%
Dec 31, 2020 -281.10%
Sep 30, 2020 -60.87%
Jun 30, 2020 -122.28%